At the beginning of each month I will scour the web for local independent pharmacy news stories that feature or impact pharmacies like yours. Here is the August recap.
Welcome to the new TRxADE.com public website, the first of many new and coming enhancements for TRxADE members. Before diving into the particulars of those enhancements, I wanted to share with you why we are making them. Simply put, the answer is you.
Follow us on Facebook
- Newly Added Guidance Documents December 6, 2019Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.FDA
- Acadia's Nuplazid could hit blockbuster heights after strong psychosis data: analyst December 5, 2019When Acadia trumpeted news that it would end a late-stage trial for its Nuplazid in dementia-related psychosis (DRP) early, it represented a big win for a drugmaker still stinging from a major schizophrenia flop. Now, data from that trial are giving some analysts hope that Nuplazid could hit blockbuster heights—with or without schizophrenia.Kyle Blankenship
3840 Land O' Lakes Blvd
Land O Lakes, FL 34639
9am-5pm Mon-Fri EST
Click Here For Contact Request Form